sanliadmin | Liuyang Sanli Medical Technology Development Co., Ltd.

Full support for the fight against the new coronavirus (COVID-19) ,SANLI MEIDCAL successfully developed a Virus specimen collection tube (Non-frozen type)!

At the beginning of the new coronavirus (COVID-19) outbreak, Liuyang SANLI Medical Technology Development Co., Ltd. organized a team to develop the Virus specimen collection tube needed to detect the new coronavirus (COVID-19) during the Spring Festival. The specimen tube was developed in only 10 days, greatly improving The speed of new coronavirus (COVID-19) detection.

If you don’t pay attention to this rule, it will wrong to paste barcode for blood collection tube!

sanliadmin Dec 28, 19

All the patients of serious disease in the ward must do the necessary tests two weeks a day. Each patient need use as few as eight or nine blood collection tubes and as many as about twenty blood collection tubes. The blood collection tubes are all performed by a nurse in the day shift, and

Innovation leads to development

sanliadmin Nov 25, 19

When it comes to R & D, it’s no exaggeration to say that the Chairman of SANLI GROUP Mr. Chen Pingxuan is a creative and R & D maniac. His innovative thinking, not only in the company and workshop, any problems and pain points in the Mr. Chen Pingxuan’s eye can become the source of

SANLI automatic production of blood collection tubes and needles reach 74 countries around the world

sanliadmin Nov 21, 19

As the founder of sterilized automatic venous blood collector making factory in China, SANLI group is the only enterprise that can produce glass sterilized tubes in China, and also the largest production base of automatic venous blood collector in Asia. The SANLI group has also participated in the formulation of the CHINA standard of the

2019 CMEF QINGDAO Exhibition Invitation

sanliadmin Oct 14, 19

Dear Sir/Madam, This is the invitation from LIUYANG SANLI MEDICAL TECHNOLOGYDEVELOPMENT CO.,LTD. We will participate in the QingDao CMEF&ICMD2019 , the world’s leading global Medical Convention.You and your company representatives are sincerely welcome to visit our booth. Our information about this event is as follows, Exhibition Name: QingDao CMEF&ICMD 2019 Address： Qingdao Cosmopolitan Exposition,Qingdao City, China Booth number: 1.S4N08 (Main hall) 2.LC69 (Hunan hall) Time: Oct 19 to Oct 22,2019

2019 INDONESIAN HOSPITAL EXPO Exhibition

sanliadmin Oct 09, 19

Dear Sir/Madam, This is the invitation from LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO.,LTD. We will participate in the INDONESIAN HOSPITAL EXPO Exhibition, the world’s leading global Medical Convention. You and your company representatives are sincerely welcome to visit our booth. Our information about this event is as follows, Exhibition Name: INDONESIAN HOSPITAL EXPO Address： Jakarta

What is the butterfly needle?

sanliadmin Sep 17, 19

A butterfly needle is a device used to access a vein for drawing blood or giving medications.Some medical professionals call a butterfly needle a “winged infusion set” or a “scalp vein set.” The set gets its name because there are plastic “wings” on either side of a hollow needle used to access the vein. While

Stem cell drugs are expected to be marketed in 5-10 years!

sanliadmin Aug 29, 19

In 2019, some progress has been made in clinical transformation of stem cells in China. Clinical research projects have been launched and recruited one after another. At the same time, some projects declared in the form of drugs have also obtained clinical approval, which gives a new dawn to the domestic market of stem cell

Will stem cells be able to rejuvenate in the future?

sanliadmin Aug 21, 19

What should we pay attention to in the treatment of stem cells? After bone marrow transplantation of hematopoietic stem cells, is the DNA of the recipient’s blood consistent with that of the recipient? Can mesenchymal stem cells be mass produced? Will allogeneic injection of stem cells produce rejection? What are the possibilities of research and

Recent advances in stem cell therapy

sanliadmin Jul 17, 19

Two medical centers have obtained permission to use autoimmune cells to treat cancer since the Chinese cell therapy special management system was launched in September last year. Two more projects, including the first non-cancer cell therapy, are expected to be approved by the end of this month (July), the head of China’s health authorities said

FROM OUR BLOG